AVI Developing Swine Flu Drugs | Xconomy
AVI Biopharma, a Portland, OR-based developer of RNA-based drugs, said today it has secured a contract with the US Defense Threat Reduction Agency to develop.
AVI Biopharma, a Portland, OR-based developer of RNA-based drugs, said today it has secured a contract with the US Defense Threat Reduction Agency to develop.
June 22, 2009
0